Surveys of Interest to MFM's
The Society supports its members and other clinicians in the field by promoting various research activities. SMFM does not conduct or endorse the surveys below.
However, if you meet the requirements provided by the researchers, you are invited to participate. If you do not meet the specifications, you are welcome to "browse" the survey, but please refrain from completing it. SMFM charges an administrative fee to post and distribute these surveys.
If you are interested in submitting a member or non-member survey, please review our survey process guidelines for more information.
GLP-1 Receptor Agonist Use in Postpartum Individuals: Provider PerspectivesPosted 3/12/2026
We are conducting a brief, anonymous survey to understand clinician perspectives on the potential role of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in the postpartum period. The survey focuses on perceptions of acceptability, appropriateness, feasibility, and perceived barriers to use in postpartum care.
Target audience:
Healthcare providers involved in the care of postpartum individuals, including but not limited to maternal-fetal medicine specialists, general obstetricians, cardiologists, endocrinologists, and other clinicians who manage postpartum cardiometabolic health.
Eligibility: Any licensed healthcare provider who provides clinical care to postpartum patients.
Clinical Perspectives on Non-Invasive Fetal Brain Monitoring Posted 3/9/2026
Fetal EEG is an emerging technology designed to noninvasively assess fetal brain activity and potentially improve detection of neurologic compromise beyond traditional heart rate–based monitoring.
We are inviting Maternal-Fetal Medicine physicians and clinicians involved in obstetric care to complete a brief 8-question survey indicating whether they may be interested in a follow-up conversation about clinical needs, workflow considerations, and potential applications.
Insights from these discussions will help inform ongoing clinical research and technology development.
To ensure the survey collects accurate and relevant data, respondents must meet all of the following criteria:
- Board Certification - Must be board-certified in Maternal-Fetal Medicine (MFM).
- Professional Practice - Currently practicing in a clinical or academic setting related to maternal-fetal medicine.
- Experience - Minimum of 3 years of experience managing high-risk pregnancies.
- Language - Able to read and respond in survey language, e.g., English.
Unpacking Uncertainty: Prenatal Providers’ Perceptions of Scope of Practice Amid Changing Abortion Policy Post Roe v. Wade Posted 3/2/2026
Our goal with this project is to investigate the effects of changing abortion policies on the roles and perceptions of scope of practice for prenatal genetic counselors (GCs), obstetrician-gynecologists (OB-GYNs), and maternal fetal medicine physicians (MFMs) on interdisciplinary care teams. Respondents will be asked a series of questions regarding their familiarity with abortion policy, their role(s) in providing abortion-related care, and dynamics and roles on their healthcare team. Completion of this survey is estimated to take approximately 15-20 minutes, and participants will have the opportunity to enter a raffle where 10 participants will win a $25 gift card.
Respondent requirements include:
- Must be a certified or board-eligible genetic counselor, maternal fetal medicine physician or obstetrician-gynecologist practicing in the United States.
- Must have at least one year of clinical experience.
- Must currently see prenatal patients in a clinical setting.
- Must work on a clinical team with at least one genetic counselor and at least one MFM/OB-GYN.
Understanding the Implementation of Outpatient Cervical Ripening With Cervical Ripening Balloons - A National Survey Study Posted 2/5/2026
This national survey aims to describe current practices for outpatient cervical ripening using cervical ripening balloons across U.S. clinical sites. The survey assesses institutional workflows, eligibility criteria, patient counseling, and operational considerations related to the implementation of these programs. Eligible respondents include Maternal-Fetal Medicine physicians, OB/GYN physicians, residents/fellows, advanced practice providers, nurses, and other clinicians or administrators who are involved in labor and delivery care and have familiarity with cervical ripening balloon use and related processes at their clinical site. The anonymous survey collects site-level information, takes approximately 15–30 minutes to complete, and results will be reported in aggregate to inform best practices and support program development.
Clinician Attitudes Surrounding a combined screening test for prenatal aneuploidies and recessive conditions Posted 1/21/2026
This is a quantitative research study focused on clinician attitudes toward a single-gene prenatal cfDNA screen.
Research Team: This research is being conducted by Baylor University, Rutgers University and Myriad Genetics, Inc. and has been determined exempt from IRB oversight by Advarra Institutional Review Boards (IRB#00000971).
Survey Details: 24 questions, approximately 15–20 minutes to complete.
Brief Explanation: While existing literature demonstrates the accuracy and potential value of combined single-gene cfDNA screens, little is known about clinician attitudes. This study aims to identify factors influencing adoption, perceived barriers, and opportunities to address disparities in care, inform guidelines, and shape future iterations of these tests.
Eligibility: An English-speaking healthcare professional (Ob/Gyn, genetic counselor, MFM, APP) who is practicing in a reproductive space taking care of pregnant patients in the United States.